GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

Rochelle McDonald has just been through the messiest of break-ups. “Guzman y Gomez were devastated,” she says, but 17 kilos ...

The demise of danuglipron means that its clinical-stage obesity pipeline is now represented by PF-07976016, another oral drug that targets GLP-1 and gastric inhibitory peptide (GIPR) and is in ...

Of these, 20% were GLP-1 drugs alone, with a host of other combinations such as GLP-1/gastric inhibitory peptide (GIP), GLP-1/glucagon, and GLP-1/amylin.

GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain ...

Agerberth, B. et al. Isolation of three antibacterial peptides from pig intestine: gastric inhibitory polypeptide (7–42), diazepam-binding inhibitor (32–86) and a novel factor, peptide 3910.

Mentlein, R., Gallwitz, B. & Schmidt, W. E. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide glucagon-like peptide-1 (7–36) amide, peptide histidine methionine and is ...

Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.

3. Challenges for Ocular Delivery of Protein and Peptide The success of most peptide and protein drugs depends on the ability to deliver the biologically active form at the action site of action.

Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. Here’s how they work, how ...

Why is an increase of nearly 48% in India’s coastline relevant to the UPSC exam? What is the significance of topics such as ...